1999
DOI: 10.1016/s1074-7613(00)80027-8
|View full text |Cite
|
Sign up to set email alerts
|

The Proto-Oncogene Cot Kinase Participates in CD3/CD28 Induction of NF-κB Acting through the NF-κB-Inducing Kinase and IκB Kinases

Abstract: The proto-oncogene Cot/Tpl-2 encodes a MAP3K-related serine-threonine kinase. Expression of wild type Cot activates the IkappaB kinases (IKK) leading to induction of NF-kappaB. Conversely, expression of kinase-deficient Cot inhibits CD3/CD28 but not TNF alpha induction of NF-kappaB. These findings suggest the selective involvement of Cot/Tpl-2 or a closely related kinase in the CD3/CD28 costimulatory pathway leading to induced nuclear expression of NF-kappaB. In contrast, a kinase-deficient mutant of the NF-ka… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

15
179
0
1

Year Published

1999
1999
2010
2010

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 201 publications
(195 citation statements)
references
References 57 publications
15
179
0
1
Order By: Relevance
“…Overexpression of TPL-2 also activates NFAT (nuclear factor of activated T cells) in Jurkat T cells and induces IL-2 (interleukin-2) production [22]. IL-2 induction by TPL-2 has also been suggested to involve activation of NF-κB transcription factors via the related MAP3 kinase NIK [23,24]. Transfection experiments in Jurkat T cells indicate that TPL-2 may control NF-κB activity by modulating the transactivation potential of the RelA transcription factor [25,26].…”
Section: S125mentioning
confidence: 99%
“…Overexpression of TPL-2 also activates NFAT (nuclear factor of activated T cells) in Jurkat T cells and induces IL-2 (interleukin-2) production [22]. IL-2 induction by TPL-2 has also been suggested to involve activation of NF-κB transcription factors via the related MAP3 kinase NIK [23,24]. Transfection experiments in Jurkat T cells indicate that TPL-2 may control NF-κB activity by modulating the transactivation potential of the RelA transcription factor [25,26].…”
Section: S125mentioning
confidence: 99%
“…A likely answer is that these upstream kinases have unique substrates which do not belong to the MAPK modules. In fact, MEKK1 (Nakano et al, 1998), MEKK2 and3 (Zhao andLee, 1999), Tpl2 (Belich et al, 1999;Lin et al, 1999) and TAK1 (Ninomiya-Tsuji et al, 1999) can also activate NF-kB by phosphorylating certain components in this pathway. Alternatively, the divergence of upstream kinases may be utilized by cells to discriminate and di erentially respond to a wide variety of extracellular stimuli such as growth factors, cytokines and physicochemical stressors.…”
Section: Upstream Kinases In the Jnk And P38 Modulesmentioning
confidence: 99%
“…Tpl-2 has also been implicated in the activation of nuclear factor-κB (NF-κB) [140,141]. NF-κB is a ubiquitous transcription factor that is involved in proliferation, apoptosis and the inflammatory response.…”
Section: Signal Diversification : Multi-protein Kinase Complexesmentioning
confidence: 99%
“…Ras and Raf can activate NF-κB quite efficiently, but, despite vigorous efforts, the mechanism has remained elusive. Suggestions include Tpl-2 increasing the level of active NF-κB by enhancing the proteolysis of p105, an NF-κB precursor molecule [141], or inducing the phosphorylation of IκB, marking it for destruction [140]. Rsk, an ERK-activated protein kinase, can also phosphorylate IκB on serine-32 [142].…”
Section: Signal Diversification : Multi-protein Kinase Complexesmentioning
confidence: 99%